These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9162322)
21. Adjuvant cisplatin and docetaxel for non-small cell lung cancer: the Hospital of the University of Pennsylvania experience. Weiss J; Eaby B; Stevenson J; Kucharczuk J; Cooper J; Kaiser L; Shrager J; Rengan R; Langer C; Evans T J Thorac Oncol; 2010 May; 5(5):667-72. PubMed ID: 20234321 [TBL] [Abstract][Full Text] [Related]
22. Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. Correale P; Botta C; Basile A; Pagliuchi M; Licchetta A; Martellucci I; Bestoso E; Apollinari S; Addeo R; Misso G; Romano O; Abbruzzese A; Lamberti M; Luzzi L; Gotti G; Rotundo MS; Caraglia M; Tagliaferri P Cancer Biol Ther; 2011 Jul; 12(2):112-8. PubMed ID: 21525780 [TBL] [Abstract][Full Text] [Related]
23. The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer. Vinante O; Bari M; Segati R; Azzarello G; Sampognaro E; Rosetti F; Pappagallo GL Oncology; 1993; 50(1):1-4. PubMed ID: 8380631 [TBL] [Abstract][Full Text] [Related]
24. A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. Ellis PA; Talbot DC; Nicolson MC; Priest K; Ashley S; Smith IE Br J Cancer; 1995 Jun; 71(6):1315-8. PubMed ID: 7779730 [TBL] [Abstract][Full Text] [Related]
25. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. Chen CP; Weinberg VK; Jahan TM; Jablons DM; Yom SS J Thorac Oncol; 2011 Nov; 6(11):1857-64. PubMed ID: 21964528 [TBL] [Abstract][Full Text] [Related]
26. Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Stathopoulos GP; Antoniou D; Dimitroulis J; Michalopoulou P; Bastas A; Marosis K; Stathopoulos J; Provata A; Yiamboudakis P; Veldekis D; Lolis N; Georgatou N; Toubis M; Pappas C; Tsoukalas G Ann Oncol; 2010 Nov; 21(11):2227-2232. PubMed ID: 20439345 [TBL] [Abstract][Full Text] [Related]
27. Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer. Athanasiadis I; Kies MS; Miller M; Ganzenko N; Joob A; Marymont M; Rademaker A; Gradishar WJ Clin Cancer Res; 1995 Sep; 1(9):973-9. PubMed ID: 9816069 [TBL] [Abstract][Full Text] [Related]
28. Non small cell lung cancer and chemotherapy. Nardini S Monaldi Arch Chest Dis; 1994 Apr; 49(2):177-8. PubMed ID: 8049706 [No Abstract] [Full Text] [Related]
29. Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report. Smit EF; Dingemans AM; Thunnissen FB; Hochstenbach MM; van Suylen RJ; Postmus PE J Thorac Oncol; 2010 May; 5(5):719-20. PubMed ID: 20421765 [No Abstract] [Full Text] [Related]
30. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study. Davis S; Tonato M; Crinò L; Colozza MA; Lubansky K; Grignani F Cancer; 1986 Sep; 58(5):1018-9. PubMed ID: 3015372 [TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for metastatic non-small-cell lung cancer. A case report. Abratt RP; Willcox PA; Bolding E; Hewitson RH S Afr Med J; 1990 Feb; 77(3):161-2. PubMed ID: 2154864 [TBL] [Abstract][Full Text] [Related]
32. Recent advances in etoposide therapy for non-small cell lung cancer. Bonomi P Cancer; 1991 Jan; 67(1 Suppl):254-9. PubMed ID: 1845849 [TBL] [Abstract][Full Text] [Related]
34. A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC). Lelli G; Guaraldi M; Canova N; Casadio M; Pannuti F J Chemother; 1990 Dec; 2(6):401-4. PubMed ID: 1965508 [TBL] [Abstract][Full Text] [Related]
35. Prediction of chemotherapeutic response in unresectable non-small-cell lung cancer (NSCLC) patients by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium (MTS) assay. Chen J; Cheng GH; Chen LP; Pang TY; Wang XL Asian Pac J Cancer Prev; 2013; 14(5):3057-62. PubMed ID: 23803079 [TBL] [Abstract][Full Text] [Related]
36. Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older. Kanat O; Evrensel T; Demiray M; Kurt E; Gonullu G; Arslan M; Manavoglu O; Ozkan A Lung Cancer; 2003 Aug; 41(2):233-4. PubMed ID: 12871788 [No Abstract] [Full Text] [Related]
37. Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung. Fuentes R; Dorca J; Canals E; Izquierdo A; Beltrán M; Viladiu P Lung Cancer; 1995 Jun; 12(3):259-62. PubMed ID: 7655835 [TBL] [Abstract][Full Text] [Related]
38. [Application of photodynamic therapy to reduce the amount of resection for non-small cell lung cancer]. Akopov AL; Rusanov AA; Chistiakov IV; Urtenova MA; Kazakov NV; Gerasin AV; Papaian GV Vopr Onkol; 2013; 59(6):740-4. PubMed ID: 24624784 [TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective. Berdeaux G; Hurteloup P Monaldi Arch Chest Dis; 1997 Jun; 52(3):305-6. PubMed ID: 9270264 [No Abstract] [Full Text] [Related]
40. [Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study]. Klippstein T; Graubner M; Berdel WE; Mende S; Gropp C; Diehl V; Mitrou PS Onkologie; 1983 Dec; 6(6):306-11. PubMed ID: 6366676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]